Clinical Trial Update: 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates [Phase 1]

View source ↗

Summary

Phase I trial update of decitabine with pegylated interferon-alfa-2b; the study was terminated and the page notes status with molecular correlates.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Dacogen (decitabine)
• PEG Intron (pegylated interferon alfa-2b)

Snippet

Sponsor: Nevada Cancer Institute | Conditions: Cancer | Phase 1 | Status: TERMINATED